Advertisement

Lung

, Volume 168, Supplement 1, pp 645–652 | Cite as

Inhalation delivery of asthma drugs

  • Heinrich Matthys
Development Of Inhalation Therapy

Abstract

In the immediate future, metered-dose inhalers (MDIs) with spacers remain the aerosol application of choice for topical steroids, mainly to reduce side effects. Forβ 2-agonist, anticholinergics and prophylactic drugs, MDI (with or without demand valve), dry powder inhalers (multidose inhalers), ultrasonic or jet aerosol generators (with or without mechanical breathing assistance [IPPB]) are chosen according to the preference or the ability of the patients to perform the necessary breathing maneuvers as well as the availability of different products in different countries.

Key words

Metered-dose inhalers Topical steroids β2-agonist Anticholinergics Prophylactic drugs 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dolowich M (1989) Physical principles underlying aerosol therapy. J Aerosol Med 2:171CrossRefGoogle Scholar
  2. 2.
    Intermittent Positive Pressure Breathing Trial Group; Bethesda, Maryland, Houston (1983) Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. Ann Intern Med 99:612Google Scholar
  3. 3.
    Köhler D, Fleischer W, Matthys H (1988) A new method for easy labelling ofβ 2-agonists in metered dose inhalers with 99 m technecium. Respiration 53:65PubMedCrossRefGoogle Scholar
  4. 4.
    Kradjan WA (1985) Efficacy of air compressor driven nebulizers. Chest 87:512PubMedCrossRefGoogle Scholar
  5. 5.
    Krieger E (1977) Wirkung verschiedener Teilchenspektren bei der Aerosoltherapie mit einem Beta-Adrenergikum. Med Technik, 97:7Google Scholar
  6. 6.
    Matthys H, Köhler D (1988) Aerosoltherapie. Prax Klin Pneumol 42:314PubMedGoogle Scholar
  7. 7.
    Matthys H, Köhler D (1985) Pulmonary deposition of aerosols by different mechanical devices. Respiration 48:269PubMedCrossRefGoogle Scholar
  8. 8.
    Matthys H, Eltschka R, App EM (1988) Deposition eines markiertenβ 2-Sympathikomimetikum-Aerosols. Atemw-Lungenkrkh. 10:485Google Scholar
  9. 9.
    Newman SP, Moren F, Trofast E, Woodman G, Clarke SW (1987) Deposition patterns in man from turbuhaler: a preliminary report. In: Newman SP, Moran F, Crompton GK (eds) A new concept in inhalation therapy. Medicom, The Netherlands, p 104Google Scholar
  10. 10.
    Persson G, Wirén JE (1989) The bronchodilator response from inhaled terbutaline is influenced by mass of small particles: a study on a dry powder inhaler (TurbuhalerR). Eur Respir J 2:253PubMedGoogle Scholar
  11. 11.
    Plomp P, Fonteijn PB, Andersoon JAR (1987) Effect of relative humidity on particle size distribution from Turbuhaler. In: Newman SP, Moran F, Crompton GK (eds) A new concept in inhalation therapy. Medicom, the Netherlands, p 100Google Scholar
  12. 12.
    Raabe OG, Lee JIC, Wong GA (1989) A signal actuated nebulizer for use with breathing machines. J Aerosol Med 2:201CrossRefGoogle Scholar
  13. 13.
    Rees PJ, Clark THJ (1982) The importance of particle size in response to inhaled bronchodilators. Eur J Respir Dis (Suppl 119):63Google Scholar
  14. 14.
    Pederson S Good inhalation practice. Trends in inhalation therapy. A symposium report. Based on a meeting held at the XIIIth International Congress of Allergology and Clinical Immunology. Montreux, Switzerland, October 18, 1988, p 7Google Scholar

Copyright information

© Springer-Verlag New York Inc 1990

Authors and Affiliations

  • Heinrich Matthys
    • 1
  1. 1.Division of Pneumology, Medical DepartmentUniversity of FreiburgFreiburgFederal Republic of Germany

Personalised recommendations